Key highlights
13 June 2023 – 1 mins read
LinkedIn
Twitter
Facebook
U.S. FDA approves Bylvay® for patients living with cholestatic pruritus due to Alagille syndrome
PARIS, FRANCE, 13 June 2023 – Ipsen (Euronext: IPN: ADR: IPSEY) today announced that the U.S. Food and Drug Administration (FDA) has approved Bylvay® (odevixibat) for the treatment of cholestatic pruritus in patients from 12 months of age with Alagille…
27 April 2023 – 1 mins read
Ipsen delivers robust sales growth in the first quarter of 2023 and confirms its full-year guidance
Paris (France), 27 April 2023
Explore more press releases
Filter
Topics
Period
Filter by
recent search
Showing: 1 – 05 of 211 Press Releases
–
15 May 2024
15 May 2024
Testing PR Pages
Information relating to the holding of the Combined Shareholders’ Meeting of 28 May 2024 of Ipsen S.A.
–
07 May 2024
07 May 2024
Ipsen S.A. – Formalities for making available and consulting preparatory documents to the 2024 Annual General Meeting
Information relating to the holding of the Combined Shareholders’ Meeting of 28 May 2024 of Ipsen S.A.
–
06 May 2024
06 May 2024
Ipsen – Monthly information relative to the total number of voting rights and shares composing the share capital
Monthly information relative to the total number of voting rights and shares composing the share capital
–
02 May 2024
02 May 2024
Ipsen appoints Keira Driansky as EVP, President of North America
PARIS, FRANCE, 2 May 2024 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, announced today the appointment of Keira Driansky as EVP, President of North America, effective May 13, 2024. She will serve on the Executive Leadership…
–
02 May 2024
02 May 2024
Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance
PARIS, FRANCE, 24 April 2024 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024.
Your dedicated contacts
-
Amy Wolf
Vice-Présidente, Stratégie de la marque Corporate et Communication
-
Ioana Piscociu
Senior Manager, Media Relations
-
Related links
